Literature DB >> 34001233

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells.

M Tajes1,2, C Díez-López1,2,3,4, C Enjuanes1,2,5, P Moliner1,2,5, J L Ferreiro1,2, A Garay1,2,5, S Jiménez-Marrero1,2,5, S Yun1,5,6, S G Sosa1,2, L Alcoberro1,2,5, J González-Costello1,2,3,4, E García-Romero1,2,3, L Yañez-Bisbe7, B Benito7,8,9, J Comín-Colet10,11,12,13.   

Abstract

BACKGROUND: Iron deficiency (ID) is common in patients with heart failure (HF) and is associated with poor outcomes, yet its role in the pathophysiology of HF is not well-defined. We sought to determine the consequences of HF neurohormonal activation in iron homeostasis and mitochondrial function in cardiac cells.
METHODS: HF was induced in C57BL/6 mice by using isoproterenol osmotic pumps and embryonic rat heart-derived H9c2 cells were subsequently challenged with Angiotensin II and/or Norepinephrine. The expression of several genes and proteins related to intracellular iron metabolism were assessed by Real time-PCR and immunoblotting, respectively. The intracellular iron levels were also determined. Mitochondrial function was analyzed by studying the mitochondrial membrane potential, the accumulation of radical oxygen species (ROS) and the adenosine triphosphate (ATP) production.
RESULTS: Hearts from isoproterenol-stimulated mice showed a decreased in both mRNA and protein levels of iron regulatory proteins, transferrin receptor 1, ferroportin 1 and hepcidin compared to control mice. Furthermore, mitoferrin 2 and mitochondrial ferritin were also downregulated in the hearts from HF mice. Similar data regarding these key iron regulatory molecules were found in the H9c2 cells challenged with neurohormonal stimuli. Accordingly, a depletion of intracellular iron levels was found in the stimulated cells compared to non-stimulated cells, as well as in the hearts from the isoproterenol-induced HF mice. Finally, neurohormonal activation impaired mitochondrial function as indicated by the accumulation of ROS, the impaired mitochondrial membrane potential and the decrease in the ATP levels in the cardiac cells.
CONCLUSIONS: HF characteristic neurohormonal activation induced changes in the regulation of key molecules involved in iron homeostasis, reduced intracellular iron levels and impaired mitochondrial function. The current results suggest that iron could be involved in the pathophysiology of HF.

Entities:  

Keywords:  Cardiac cell; Heart failure; Iron deficiency; Mitochondria function; Neurohormonal activation

Year:  2021        PMID: 34001233     DOI: 10.1186/s13578-021-00605-5

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  38 in total

1.  Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.

Authors:  Cristina Enjuanes; Ijsbrand T Klip; Jordi Bruguera; Merce Cladellas; Piotr Ponikowski; Waldemar Banasiak; Dirk J van Veldhuisen; Peter van der Meer; Ewa A Jankowska; Josep Comín-Colet
Journal:  Int J Cardiol       Date:  2014-04-03       Impact factor: 4.164

2.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

3.  Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.

Authors:  Nuria Farré; Emili Vela; Montse Clèries; Montse Bustins; Miguel Cainzos-Achirica; Cristina Enjuanes; Pedro Moliner; Sonia Ruiz; Jose Maria Verdú-Rotellar; Josep Comín-Colet
Journal:  Eur J Heart Fail       Date:  2016-04-25       Impact factor: 15.534

Review 4.  Neurohormonal activation in heart failure with reduced ejection fraction.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2016-10-06       Impact factor: 32.419

5.  Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach.

Authors:  Daniel G Kramer; Thomas A Trikalinos; David M Kent; George V Antonopoulos; Marvin A Konstam; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2010-07-27       Impact factor: 24.094

6.  Iron deficiency in chronic heart failure: an international pooled analysis.

Authors:  Ijsbrand T Klip; Josep Comin-Colet; Adriaan A Voors; Piotr Ponikowski; Cristina Enjuanes; Waldemar Banasiak; Dirk J Lok; Piotr Rosentryt; Ainhoa Torrens; Lech Polonski; Dirk J van Veldhuisen; Peter van der Meer; Ewa A Jankowska
Journal:  Am Heart J       Date:  2013-02-22       Impact factor: 4.749

7.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 8.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.

Authors:  Filippos Triposkiadis; George Karayannis; Grigorios Giamouzis; John Skoularigis; George Louridas; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.

Authors:  José González-Costello; Josep Comín-Colet; Josep Lupón; Cristina Enjuanes; Marta de Antonio; Lara Fuentes; Pedro Moliner-Borja; Nuria Farré; Elisabet Zamora; Nicolás Manito; Ramón Pujol; Antoni Bayés-Genis
Journal:  BMC Cardiovasc Disord       Date:  2018-11-01       Impact factor: 2.298

View more
  4 in total

Review 1.  Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.

Authors:  Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.964

2.  Hemosiderin Accumulation in Liver Decreases Iron Availability in Tachycardia-Induced Porcine Congestive Heart Failure Model.

Authors:  Monika Kasztura; Liliana Kiczak; Urszula Pasławska; Jacek Bania; Adrian Janiszewski; Alicja Tomaszek; Maciej Zacharski; Agnieszka Noszczyk-Nowak; Robert Pasławski; Aleksandra Tabiś; Piotr Kuropka; Piotr Dzięgiel; Piotr Ponikowski
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

3.  Expression of Iron Metabolism Proteins in Patients with Chronic Heart Failure.

Authors:  Bogna Kozłowska; Barbara Sochanowicz; Leszek Kraj; Małgorzata Palusińska; Piotr Kołsut; Łukasz Szymański; Sławomir Lewicki; Witold Śmigielski; Marcin Kruszewski; Przemysław Leszek
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

Review 4.  Clinical and Molecular Aspects of Iron Metabolism in Failing Myocytes.

Authors:  Bogna Kozłowska; Barbara Sochanowicz; Leszek Kraj; Małgorzata Palusińska; Piotr Kołsut; Łukasz Szymański; Sławomir Lewicki; Marcin Kruszewski; Marta Załęska-Kocięcka; Przemysław Leszek
Journal:  Life (Basel)       Date:  2022-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.